S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?

Doximity (DOCS) Stock Price, News & Analysis

$27.88
0.00 (0.00%)
(As of 03/18/2024 ET)
Today's Range
$27.62
$28.19
50-Day Range
$26.95
$31.57
52-Week Range
$19.71
$37.10
Volume
827,340 shs
Average Volume
1.81 million shs
Market Capitalization
$5.20 billion
P/E Ratio
42.24
Dividend Yield
N/A
Price Target
$28.00

Doximity MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
0.4% Upside
$28.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Doximity in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$141,350 Sold Last Quarter
Proj. Earnings Growth
5.56%
From $0.72 to $0.76 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.78 out of 5 stars

Medical Sector

733rd out of 947 stocks

Custom Computer Programming Services Industry

21st out of 26 stocks

DOCS stock logo

About Doximity Stock (NASDAQ:DOCS)

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

DOCS Stock Price History

DOCS Stock News Headlines

DOCS Apr 2024 37.500 call
What 6 Analyst Ratings Have To Say About Doximity
The world’s greatest investment
I believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.
Doximity Inc.
Forecasting The Future: 5 Analyst Projections For Doximity
DOCS Apr 2024 40.000 call
Central Bank Gold Heist In Progress
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
Doximity to Participate in Upcoming Investor Events
Doximity: Rating Upgrade To Buy As Outlook Turns Positive
DOCS Mar 2024 22.500 put
DOCS Mar 2024 35.000 call
DOCS Feb 2024 12.500 call
DOCS Aug 2024 32.500 put
DOCS Mar 2024 25.000 put
See More Headlines
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
3/19/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
5/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Custom computer programming services
Sub-Industry
N/A
Current Symbol
NASDAQ:DOCS
Fax
N/A
Employees
977
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.00
High Stock Price Target
$33.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+0.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
13 Analysts

Profitability

Net Income
$112.82 million
Pretax Margin
37.15%

Debt

Sales & Book Value

Annual Sales
$468.33 million
Cash Flow
$0.72 per share
Book Value
$4.98 per share

Miscellaneous

Free Float
113,052,000
Market Cap
$5.20 billion
Optionable
Not Optionable
Beta
1.18
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


DOCS Stock Analysis - Frequently Asked Questions

Should I buy or sell Doximity stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 2 sell ratings, 9 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
View DOCS analyst ratings
or view top-rated stocks.

What is Doximity's stock price target for 2024?

13 brokerages have issued 12-month price targets for Doximity's stock. Their DOCS share price targets range from $21.00 to $33.00. On average, they predict the company's stock price to reach $28.00 in the next twelve months. This suggests a possible upside of 0.4% from the stock's current price.
View analysts price targets for DOCS
or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2024?

Doximity's stock was trading at $28.04 at the beginning of 2024. Since then, DOCS stock has decreased by 0.6% and is now trading at $27.88.
View the best growth stocks for 2024 here
.

When is Doximity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 21st 2024.
View our DOCS earnings forecast
.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) posted its quarterly earnings results on Thursday, February, 8th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.06. The business had revenue of $135.28 million for the quarter, compared to analyst estimates of $127.46 million. Doximity had a trailing twelve-month return on equity of 16.08% and a net margin of 29.39%.

What guidance has Doximity issued on next quarter's earnings?

Doximity updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $473.3 million-$474.3 million, compared to the consensus revenue estimate of $467.3 million.

When did Doximity IPO?

(DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Who are Doximity's major shareholders?

Doximity's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.86%), Vanguard Group Inc. (5.84%), Baillie Gifford & Co. (3.39%), Clearbridge Investments LLC (3.19%), Edmond DE Rothschild Holding S.A. (1.24%) and Norges Bank (0.69%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral.
View institutional ownership trends
.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DOCS) was last updated on 3/19/2024 by MarketBeat.com Staff

From Our Partners